Abstract
Soon after the discovery of neutrons by Chadwick at Cambridge University, Goldhaber noticed the release of an alpha particle as a neutron hits an atom. Although we do not know the exact origin of the idea, the possibility that such neutron capture reaction could be used for cancer treatment was initially mentioned in 1936 by an American physicist, Locher [1] of Swarthmore College. The idea that neutron capture reaction might be used for cancer treatment gradually took on more shape as a few scientists [2–4] conducted animal studies between 1940 and 1951. Clinical trials were started in 1951 at Brookhaven National Laboratory by Sweet and Javid [5], Javid et al. [6] and Farr et al. [7]. This naturally aroused interest in Europe [8] and Japan [9] as well. But the trials were discontinued after 17 glioblastoma cases were treated at Massachusetts Institute of Technology in 1960 and 1961. In 1961, boron-neutron capture therapy (BNCT) was virtually dead because of the discouraging clinical results of the MIT series [10]. It was in 1964 that the author was given a chance to study the therapy when he arrived at Harvard Medical School as an Exchange Scholar with the support of a Fulbright Travel Grant [11]. He worked with Prof. William H. Sweet, then Chief of the Neurosurgical Service at Massachusetts General Hospital, between July 1964 and July 1967. Other associates included A. H. Soloway, a chemist, and G. L. Brownell, a physicist. Sweet had not lost his enthusiasm for BNCT, although he was never to be able to resume clinical trials again during his tenure; the research still being conducted was limited to the basic aspect.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Locher OL (1936) Biological effects and therapeutic possibilities of neutron. AJR 36: 1–13
Kruger PG (1940) Some biological effects of nuclear disintegration products on neoplastic tissue. Proc Natl Acad Sci USA 26: 181
Zahl PA, Cooper FS (1941) Localization of lithium in tumor tissue as a basis for slow neutron therapy. Science 93 (2403): 64–65
Zahl PA, Cooper FS, Dunning JR (1940) Some in vivo effects of localized nuclear disintegration products on a transplantable mouse sarcoma. Proc Natl Acad Sci USA 26: 589
Sweet WH, Javid M (1952) The possible use of neutron-capturing isotopes such as boron-10 in the treatment of neoplasms. I. Intracranial tumor. J Neurosurg 9: 200–209
Javid M, Brownell GL, Sweet WH (1952) The possible use of neutron-capturing isotopes such as boron-10 in the treatment of neoplasms. II. Computation of the radiation energy and estimates of effects in normal and neoplastic brain. J Clin Invest 31: 603–610
Farr LE, Sweet WH, Robertson JS, Foster CG, Locksley HB, Sutherland DL, Mendelsohn ML, Stickley EE (1954) Neutron capture therapy with boron in the treatment of glioblastoma multiforme. AJR 71: 279–293
Entzian W, Soloway AH, Raju R, Sweet WH, Brownell GL (1966) Effect of neutron capture irradiation upon malignant brain tumors in mice. Acta Radiol (Stockh) 5: 95–100
Miyakawa T, Watanabe N (1960) Applicability of neutron capture therapy using colloidal boron. Nippon Igaku Hoshasen Gakkai Zasshi 19: 2104–2114
Asbury AK, Ojemann RG, Nielsen SL, Sweet WH (1972) Neuropathological study on fourteen cases of malignant tumors treated by boron-10 slow neutron capture therapy. J Neuropathol Exp Neurol 31: 278–303
Hatanaka H (1986) Introduction. In: Hatanaka H (ed) Boron-neutron capture therapy for tumors. Nishimura, Niigata, pp 1–28
Hatanaka H (1968) Blood-brain barrier and brain edema (in Japanese). Igaku No Ayumi 64: 688–698
Soloway AH, Hatanaka H, Davis MA (1967) Penetration of brain and brain tumor. VII. Tumor-binding sulfhydryl boron compounds. J Med Chem 10: 714–717
Hatanaka H (1971) Boron-neutron capture therapy of brain tumors. As viewed by a man acquainted with both U. S. and Japanese research projects (in Japanese). Igaku No Ayumi 76: 181–188
Kitao K (1975) A method for calculating the absorbed dose near interface from 10B (n,a)’Li reaction. Radiat Res 61: 304–315
Rydin RA, Deutsch OL, Murray BW (1976) The effect of geometry on capillary wall dose for boron neutron capture therapy. Phys Med Biol 21: 134
Nakagawa T, Yoshizaki T, Aono K (1975) Houso-chuseishi-hosoku-ryoho-zai no shinki-seizouhou (A new method to produce a new boron compound for boron-neutron capture therapy) -JPN 50–92897. Japan Patent Koukaikouhou, 92897
Ikeuchi I, Amano T (1985) Isotachophoretic analysis of mercaptoundecahydrododecaborate anion in human serum and urine. Chem Pharm Bull (Tokyo) 33: 2553–2555
Hatanaka H, Watanabe N (1970) Brain tumor treatment with slow neutrons (in Japanese). Geka Shinryo 12: 1041–1055
Matsuoka O, Hatanaka H, Miyamoto M (1977) Neutron capture whole body autoradiography of 10B compounds. Acta Pharmacol Toxicol (Copenh) [Suppl 1] 41: 56–57
Amano K, Sweet WH (1973) Alpha-autoradiography of 10B-compound distribution in tissue by use of superimposition technique. Nippon Igaku Hoshasen Gakkai Zasshi 33: 267
Abe M (1982) 10B compound distribution in rat tissue of transplanted and ethylnitrosourea-induced brain tumors. Fukuoka Igaku Zasshi 73:250–271
Abe M, Amano K, Kitamura K, Tateishi J, Hatanaka H (1983) Boron-10 distribution in rat brain tumors. In: Fairchild RG, Brownell GL (eds) Proceedings of the first international symposium on neutron capture therapy. Brookhaven National Laboratory, Upton, pp 155–158
Abe M, Amano K, Kitamura K, Tateishi J, Hatanaka H (1984) Boron-10 distribution in rat brain tumors. In: Hatanaka H (ed) Cooperative study on slow neutron capture therapy. Ministry of Education, Science and Culture, pp 87–95
Hatanaka H, Amano K, Kanemitsu H, Ikeuchi I, Yoshizaki T (1986) Boron uptake by human brain tumors and quality control of boron compounds. In: Hatanaka H (ed) Boron-neutron capture therapy for tumors Nishimura, Niigata, pp 77–106
Hatanaka H (ed) (1986) Boron-neutron capture therapy for tumors. Nishimura, Niigata
Hatanaka H, Masuzawa T, Amano K, Sano K (1968) Basic and clinical studies on boron-neutron capture therapy. Nippon Acta Neuroradiol 9: 37–40
Hatanaka H, Sano K (1972) A revised boron-neutron capture therapy for malignant brain tumors. In: Fusek I, Kunc Z (eds) Present limits in neurosurgery. Avicenum-Czechoslovak Medical Press, Prague, pp 83–85
Hatanaka H, Sano K (1973) A revised boron-neutron capture therapy for malignant brain tumors. I. Experience on terminally ill patients after cobalt-60 radiotherapy. J Neurol 204: 309–332
Brownell GL (1973) A reassessment of neutron capture therapy in the treatment of cerebral gliomas. In: Proceedings of the 7th National Cancer Conference, p. 827–837
Hatanaka H (1988) Experience of boron neutron capture therapy for malignant brain tumours — with special reference to the problems of post-operative CT follow-ups. Acta Neurochir (Wien) 42: 187–192
Nozaki T, Matsumoto T, Aizawa O (1979) Thermal neutron distribution in a head phantom apposed to the collimator for boron-neutron capture therapy. Bull At Energy Res Lab Musashi Inst Technol 1: 75–77
Minobe T, Hatanaka H (1986) Remote control anesthesia for neutron capture therapy of malignant brain tumors. In: Hatanaka H (ed) Boron-neutron capture therapy for tumors. Nishimura, Niigata, pp 451–456
Hayakawa Y, Harasawa S, Nakamoto A, Amano K, Hatanaka H, Egawa J (1978) Simultaneous monitoring system of thermal neutron flux for boron neutron capture therapy. Radiat Res 75: 243–251
Hatanaka H, Moritani M, Camillo M, Takagaki M, Takeuchi A, Abe M, Nakagawa Y, Ushio Y (1988) Basic studies on neutron capture therapy — a basic study on the possibility of a fractionated boron-neutron capture therapy. Progress Report on Joint Utilization of the Musashi Reactor 13: 31–34
Kirsch JE, Brownell GL, Zamenhoff RG, Sweet WH, Messer JR, Richardson EP, Takeuchi A, Hatanaka H (1986) Irradiation of normal canine brain after craniectomy with the current boron neutron capture therapy regimen at MIT-reactor. In: Hatanaka,H (ed) Boron-neutron capture therapy for tumors. Nishimura, Niigata, pp 147–160
Ushio Y, Hayakawa T, Morimoto K, Mogami H, Takeuchi A, Amano K, Minobe T, Hatanaka H (1986) Pathological study of the effect of boron-neutron capture radiation on normal brains of dogs. In: Hatanaka H (ed) Boron-neutron capture therapy for tumors. Nishimura, Niigata, pp 161–174
Takeuchi A, Hatanaka H (1986) Tolerance of canine brain to the revised boron neutron capture therapy. In: Hatanaka H (ed) Boron-neutron capture therapy for tumors Nishimura, Niigata, pp 175–184
Al-Samarrai SF, Hatanaka H (1986) Ultrastructural studies on response of normal cerebral capillaries to boron neutron capture therapy. In: Hatanaka H (ed) Boron-neutron capture therapy for tumors. Nishimura, Niigata, pp 185–190
Hatanaka H, Urano Y (1986) Eighteen autopsy cases of malignant brain tumors treated by boron-neutron capture therapy between 1968 and 1985. In: Hatanaka H (ed) Boron-neutron capture therapy for tumors. Nishimura, Niigata, pp 381–416
Morstin K, Kawecka N, Feinendegen LE (1983) Remarks on the optimization of incident neutron energy for neutron capture therapy. In: Fairchild RG, Brownell GL (eds) Proceedings of the first international symposium on neutron capture therapy. Brookhaven National Laboratory, Upton, pp 114–119
Kadosawa T, Takeuchi A, Nakaichi T, Matsumoto T, Nozaki T, Aizawa O, Takagaki M, Moritani M, Amano K, Hatanaka H, Hayakawa Y, Inada T (1987) Basic research in neutron capture therapy I. Preliminary study on the use of D2O for boron-neutron capture therapy. Annu Rep Joint Stud Musashi Inst Technol React 12: 9–16
Katz JJ, Crespi HL, Czajka DM, Finkel AJ (1962) Course of deuteriation and some phsyiological effects of deuterium in mice. Am J Physiol 203: 907–913
Windholz M, Budavari S, Stroumtsos LY, Fertig MN (1976) Deuterium oxide. In: Windholz M et al. (eds) Merck index, Merck, Rahway, p 385
Aranyi P (1984) Kinetic deuterium isotope effects in glucocorticoid receptor activation. J Recept Res 4: 385–396
Dourish CT, Dewar KM, Dyck LE, Boulton AA (1983) Potentiation of the behavioural effects of the antidepressant phenelzine by deuterium substitution. Psychopharmoclogy (Berlin) 81: 122–125
Kiszenick W, Fairchild RG, Slatkin DN, Zubal G (1984) Increased neutron penetration in partially deuterated water: application to neutron capture therapy. Med Phys 11 (1): 26–30
Gatley SJ, Wess MM, Govoni PL, Wagner A, Katz JJ, Friedman AM (1986) Deuterioglucose: alteration of biodistribution by an isotope effect. J Nucl Med 27: 388–394
Khaled MA, Lukashi HC, Watkins CL (1987) Determination of total body water by deuterium NMR1–3. AM J Clin Nutr 45: 1–6
Hatanaka H, Urano Y, Seto K (1989) Pathological studies on maximum therapeutic depth by the current standard technique of BNCT. 3rd International Symposium on Neutron Capture Therapy (Session 14), May 31—June 3, Bremen
Fujii T, Nakanishi H, Hatanaka H (1987) Basic research in neutron capture therapy II. Preliminary study on the use of D2O for boron-neutron capture therapy. Tolerance of D2O. Annu Rep Joint Stud Musashi Inst Technol React 12: 17–23
Hatanaka H, Kamano S, Amano K, Hojo S, Sano K, Egawa S, Yasukouchi H (1986) Clinical experience of boron-neutron capture therapy for gliomas — a comparison with conventional chemo-immure-radiotherapy. In: Hatanaka H (ed) Boron-neutron capture therapy for tumors Nishimura, Niigata, pp 349–380
Hatanaka H (1990) Clinical results of boron-neutron capture therapy. In: Harling O, Bernard J, Zamenoff RG (eds) Neutron beam design, development and performance for neutron capture therapy. Plenum, New York, pp 15–21
Takahashi T, Fujii Y, Fujii G, Yasuda T, Nariuchi H (1986) Feasibility study for boron-neutron capture therapy using monoclonal antibody to tumor-associated antigens. In: Hatanaka H (ed) Neutron capture therapy Nishimura, Niigata, pp 382–386
Yanagie H, Fujii Y, Takahashi T, Tornita T, Fukano Y, Hasumi K, Nariuchi H, Yasuda T, Sekiguchi M, Uchida H, Kobayashi H (1989) Boron-neutron capture therapy using 10B-entrapped anti-CEA immunoliposome. Hum Cell 2: 290–296
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Hatanaka, H. (1991). Boron-Neutron Capture Therapy for Tumors. In: Karim, A.B.M.F., Laws, E.R. (eds) Glioma. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-84127-9_18
Download citation
DOI: https://doi.org/10.1007/978-3-642-84127-9_18
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-52286-7
Online ISBN: 978-3-642-84127-9
eBook Packages: Springer Book Archive